|
US8030343B2
(en)
*
|
2000-06-08 |
2011-10-04 |
Celgene Corporation |
Pharmaceutically active isoindoline derivatives
|
|
US7311905B2
(en)
*
|
2002-02-13 |
2007-12-25 |
Anthrogenesis Corporation |
Embryonic-like stem cells derived from post-partum mammalian placenta, and uses and methods of treatment using said cells
|
|
DK1349918T3
(da)
|
2000-12-06 |
2014-11-10 |
Anthrogenesis Corp |
Fremgangsmåde til indsamling af stamceller fra moderkagen
|
|
EP3246396B1
(en)
|
2001-02-14 |
2020-01-29 |
Celularity, Inc. |
Renovation and repopulation of decellularized tissues and cadaveric organs by stem cells
|
|
US7498171B2
(en)
*
|
2002-04-12 |
2009-03-03 |
Anthrogenesis Corporation |
Modulation of stem and progenitor cell differentiation, assays, and uses thereof
|
|
CN1713905A
(zh)
|
2002-10-15 |
2005-12-28 |
细胞基因公司 |
用于治疗骨髓增生异常综合征的选择性细胞因子抑制药
|
|
AU2003298775B2
(en)
*
|
2002-11-26 |
2008-07-17 |
Anthrogenesis Corporation |
Cytotherapeutics, cytotherapeutic units and methods for treatments using them
|
|
US20050143344A1
(en)
*
|
2003-12-30 |
2005-06-30 |
Zeldis Jerome B. |
Methods and compositions using immunomodulatory compounds for the treatment and management of central nervous system disorders or diseases
|
|
CN1961283A
(zh)
*
|
2004-03-26 |
2007-05-09 |
细胞基因公司 |
建立干细胞库的系统和方法
|
|
US20080213213A1
(en)
*
|
2004-04-14 |
2008-09-04 |
Zeldis Jerome B |
Method For the Treatment of Myelodysplastic Syndromes Using (+)-2-[1-(3-Ethoxy-4-Methoxyphenyl)-2-Methylsulfonylethyl]-4-Acetylaminoisoindoline-1,3-Dione
|
|
US7244759B2
(en)
*
|
2004-07-28 |
2007-07-17 |
Celgene Corporation |
Isoindoline compounds and methods of making and using the same
|
|
KR20070092276A
(ko)
*
|
2004-12-13 |
2007-09-12 |
셀진 코포레이션 |
Ｐｄｅ４ 조절인자를 포함하는 조성물 및 이의 기도염의치료 또는 예방을 위한 용도
|
|
AU2006265601A1
(en)
*
|
2005-06-30 |
2007-01-11 |
Anthrogenesis Corporation |
Repair of tympanic membrane using placenta derived collagen biofabric
|
|
MX2007016290A
(es)
|
2005-06-30 |
2008-03-10 |
Celgene Corp |
Procesos para la preparacion de compuestos de 4-amino-2(2,6-dioxopiperidin-3-il)isoindolin-1,3-diona.
|
|
US7928280B2
(en)
*
|
2005-07-13 |
2011-04-19 |
Anthrogenesis Corporation |
Treatment of leg ulcers using placenta derived collagen biofabric
|
|
US20070021762A1
(en)
*
|
2005-07-13 |
2007-01-25 |
Qing Liu |
Ocular plug formed from placenta derived collagen biofabric
|
|
US20070066512A1
(en)
*
|
2005-09-12 |
2007-03-22 |
Dominique Verhelle |
Methods and compositions using immunomodulatory compounds for the treatment of disorders associated with low plasma leptin levels
|
|
US7878970B2
(en)
|
2005-09-28 |
2011-02-01 |
Boston Scientific Scimed, Inc. |
Apparatus and method for suspending a uterus
|
|
CN101326281A
(zh)
*
|
2005-10-13 |
2008-12-17 |
人类起源公司 |
用源自胎盘的干细胞制备少突胶质细胞
|
|
DK1957633T3
(en)
|
2005-10-13 |
2014-03-17 |
Anthrogenesis Corp |
Immunomodulation USING PLACE SPEECH STEM CELLS
|
|
CA2633980A1
(en)
*
|
2005-12-29 |
2007-07-12 |
Anthrogenesis Corporation |
Improved composition for collecting and preserving placental stem cells and methods of using the composition
|
|
CN101389754A
(zh)
*
|
2005-12-29 |
2009-03-18 |
人类起源公司 |
胎盘干细胞和第二来源干细胞的联合培养
|
|
PT2471904T
(pt)
|
2005-12-29 |
2019-02-25 |
Celularity Inc |
População de células estaminais placentárias
|
|
US9144483B2
(en)
|
2006-01-13 |
2015-09-29 |
Boston Scientific Scimed, Inc. |
Placing fixation devices
|
|
EP1998711B1
(en)
|
2006-03-16 |
2013-12-11 |
Boston Scientific Limited |
Apparatus for treatment of pelvic conditions
|
|
US20080064876A1
(en)
*
|
2006-05-16 |
2008-03-13 |
Muller George W |
Process for the preparation of substituted 2-(2,6-dioxopiperidin-3-yl)isoindole-1,3-dione
|
|
TW200806625A
(en)
*
|
2006-05-26 |
2008-02-01 |
Astrazeneca Ab |
Therapeutic compounds
|
|
US7993918B2
(en)
|
2006-08-04 |
2011-08-09 |
Anthrogenesis Corporation |
Tumor suppression using placental stem cells
|
|
WO2008021391A1
(en)
*
|
2006-08-15 |
2008-02-21 |
Anthrogenesis Corporation |
Umbilical cord biomaterial for medical use
|
|
US20080131522A1
(en)
*
|
2006-10-03 |
2008-06-05 |
Qing Liu |
Use of placental biomaterial for ocular surgery
|
|
WO2008060377A2
(en)
|
2006-10-04 |
2008-05-22 |
Anthrogenesis Corporation |
Placental or umbilical cord tissue compositions
|
|
KR20230146124A
(ko)
*
|
2006-10-06 |
2023-10-18 |
셀룰래리티 인코포레이티드 |
천연(텔로펩티드) 태반 콜라겐 조성물
|
|
ZA200902233B
(en)
|
2006-10-23 |
2010-07-28 |
Anthrogenesis Corp |
Methods and compositions for treatment of bone defects with placental cell populations
|
|
EP3763376A1
(en)
|
2007-02-12 |
2021-01-13 |
Celularity, Inc. |
Treatment of inflammatory diseases using placental stem cells
|
|
AU2008216748A1
(en)
|
2007-02-12 |
2008-08-21 |
Anthrogenesis Corporation |
Hepatocytes and chondrocytes from adherent placental stem cells; and CD34+, CD45- placental stem cell-enriched cell populations
|
|
US9200253B1
(en)
|
2007-08-06 |
2015-12-01 |
Anthrogenesis Corporation |
Method of producing erythrocytes
|
|
NZ599825A
(en)
|
2007-09-28 |
2014-10-31 |
Anthrogenesis Corp |
Tumor suppression using human placental perfusate and human placenta-derived intermediate natural killer cells
|
|
WO2009073146A2
(en)
*
|
2007-11-29 |
2009-06-11 |
Celgene Corporation |
Use of immunomodulatory compounds for the treatment of transverse myelitis, multiple sclerosis, and other disorders
|
|
WO2009085234A2
(en)
|
2007-12-20 |
2009-07-09 |
Signal Pharmaceuticals, Inc. |
Use of micro-rna as a biomarker of immunomodulatory drug activity
|
|
US8430807B2
(en)
|
2007-12-28 |
2013-04-30 |
Boston Scientific Scimed, Inc. |
Devices and methods for treating pelvic floor dysfunctions
|
|
US9078728B2
(en)
|
2007-12-28 |
2015-07-14 |
Boston Scientific Scimed, Inc. |
Devices and methods for delivering female pelvic floor implants
|
|
WO2009105256A2
(en)
*
|
2008-02-20 |
2009-08-27 |
Celgene Corporation |
Method of treating cancer by administering an immunomodulatory compound in combination with a cd40 antibody or cd40 ligand
|
|
KR20240052847A
(ko)
|
2008-08-20 |
2024-04-23 |
셀룰래리티 인코포레이티드 |
개선된 세포 조성물 및 그의 제조 방법
|
|
CA2734446C
(en)
|
2008-08-22 |
2017-06-20 |
Anthrogenesis Corporation |
Methods and compositions for treatment of bone defects with placental cell populations
|
|
AU2009316541B2
(en)
|
2008-11-19 |
2015-08-06 |
Celularity Inc. |
Amnion derived adherent cells
|
|
EP2395995A1
(en)
|
2009-02-10 |
2011-12-21 |
Celgene Corporation |
Methods of using and compositions comprising pde4 modulators for treatment, prevention and management of tuberculosis
|
|
EP3489352A1
(en)
|
2009-03-25 |
2019-05-29 |
Celularity, Inc. |
Tumor suppression using human placenta-derived intermediate natural killer cells and immunomodulatory compounds
|
|
US9125716B2
(en)
|
2009-04-17 |
2015-09-08 |
Boston Scientific Scimed, Inc. |
Delivery sleeve for pelvic floor implants
|
|
EP2436387B1
(en)
|
2009-05-25 |
2018-07-25 |
Celgene Corporation |
Pharmaceutical composition comprising crbn for use in treating a disease of the cerebral cortex
|
|
ES2469849T3
(es)
*
|
2009-06-18 |
2014-06-20 |
Concert Pharmaceuticals Inc. |
Derivados deuterados de isoindolin-1,3-diona como inhibidores de PDE4 y TNF-alfa
|
|
AU2013263763B2
(en)
*
|
2009-06-18 |
2016-05-19 |
Concert Pharmaceuticals, Inc. |
Deuterated isoindoline-1,3-dione derivatives as PDE4 and TNF-alpha inhibitors
|
|
US8586360B2
(en)
|
2009-07-02 |
2013-11-19 |
Anthrogenesis Corporation |
Method of producing erythrocytes without feeder cells
|
|
ES2451350T3
(es)
*
|
2009-10-09 |
2014-03-26 |
Celgene Corporation |
Procedimientos para la preparación de compuestos de 2-(1-feniletil)isoindolin-1-ona
|
|
MX337566B
(es)
|
2010-01-05 |
2016-03-10 |
Celgene Corp |
Combinación de un compuesto inmunomodulador y una artemisinina o un derivado de ésta para tratar cáncer.
|
|
DK3284818T3
(da)
|
2010-01-26 |
2022-06-20 |
Celularity Inc |
Behandling af knoglerelateret kræft ved hjælp af placenta stamceller
|
|
PL3202460T3
(pl)
|
2010-02-11 |
2019-12-31 |
Celgene Corporation |
Pochodne arylometoksyizoindoliny i zawierające je kompozycje oraz sposoby ich zastosowania
|
|
LT2556145T
(lt)
|
2010-04-07 |
2016-11-10 |
Anthrogenesis Corporation |
Angiogenezė naudojant placentos kamienines ląsteles
|
|
MX2012011543A
(es)
|
2010-04-08 |
2013-05-06 |
Anthrogenesis Corp |
Tratamiento de sarcoidosis empleando celulas madre placentarias.
|
|
EP2583098B1
(en)
|
2010-06-15 |
2018-08-08 |
Celgene Corporation |
Biomarkers for the treatment of psoriasis
|
|
ES2666746T3
(es)
|
2010-07-13 |
2018-05-07 |
Anthrogenesis Corporation |
Métodos para generar linfocitos citolíticos naturales
|
|
US8911348B2
(en)
|
2010-09-02 |
2014-12-16 |
Boston Scientific Scimed, Inc. |
Pelvic implants and methods of implanting the same
|
|
CN106008313B
(zh)
*
|
2010-12-22 |
2018-11-13 |
康塞特医药品有限公司 |
取代的异吲哚啉-1,3二酮衍生物
|
|
US8969315B2
(en)
|
2010-12-31 |
2015-03-03 |
Anthrogenesis Corporation |
Enhancement of placental stem cell potency using modulatory RNA molecules
|
|
EP2663549B1
(en)
*
|
2011-01-10 |
2018-03-14 |
Celgene Corporation |
Phenethylsulfone isoindoline derivatives as inhibitors of pde 4 and/or cytokines
|
|
WO2012097116A2
(en)
|
2011-01-14 |
2012-07-19 |
Celgene Corporation |
Isotopologues of isoindole derivatives
|
|
WO2012145309A1
(en)
|
2011-04-18 |
2012-10-26 |
Celgene Corporation |
Biomarkers for the treatment of multiple myeloma
|
|
AU2012249491B2
(en)
|
2011-04-29 |
2016-12-15 |
Celgene Corporation |
Methods for the treatment of cancer and inflammatory diseases using cereblon as a predictor
|
|
JP6104896B2
(ja)
|
2011-06-01 |
2017-03-29 |
アントフロゲネシス コーポレーション |
胎盤幹細胞を使用する疼痛の治療
|
|
US9938269B2
(en)
|
2011-06-30 |
2018-04-10 |
Abbvie Inc. |
Inhibitor compounds of phosphodiesterase type 10A
|
|
WO2013055476A1
(en)
|
2011-09-09 |
2013-04-18 |
Anthrogenesis Corporation |
Treatment of amyotrophic lateral sclerosis using placental stem cells
|
|
US9168120B2
(en)
|
2011-09-09 |
2015-10-27 |
Boston Scientific Scimed, Inc. |
Medical device and methods of delivering the medical device
|
|
ES2872967T3
(es)
|
2012-06-29 |
2021-11-03 |
Celgene Corp |
Métodos para determinar la eficacia de fármacos usando IKZF3 (AIOLOS)
|
|
US9587281B2
(en)
|
2012-08-14 |
2017-03-07 |
Celgene Corporation |
Cereblon isoforms and their use as biomarkers for therapeutic treatment
|
|
JP5934658B2
(ja)
*
|
2013-01-29 |
2016-06-15 |
Ｊｘエネルギー株式会社 |
イミド−ウレア化合物及びその製造方法、グリース用増ちょう剤並びにグリース組成物
|
|
CN115137753A
(zh)
|
2013-02-05 |
2022-10-04 |
细胞结构公司 |
来自胎盘的自然杀伤细胞
|
|
US9814555B2
(en)
|
2013-03-12 |
2017-11-14 |
Boston Scientific Scimed, Inc. |
Medical device for pelvic floor repair and method of delivering the medical device
|
|
NZ629456A
(en)
|
2013-04-17 |
2017-06-30 |
Signal Pharm Llc |
Methods for treating cancer using tor kinase inhibitor combination therapy
|
|
US9962251B2
(en)
|
2013-10-17 |
2018-05-08 |
Boston Scientific Scimed, Inc. |
Devices and methods for delivering implants
|
|
WO2015175956A1
(en)
|
2014-05-16 |
2015-11-19 |
Celgene Corporation |
Compositions and methods for the treatment of atherosclerotic cardiovascular diseases with pde4 modulators
|
|
EP3827836A1
(en)
|
2014-06-27 |
2021-06-02 |
Celgene Corporation |
Compositions and methods for inducing conformational changes in cereblon and other e3 ubiquitin ligases
|
|
WO2017070291A1
(en)
|
2015-10-21 |
2017-04-27 |
Celgene Corporation |
Pde4 modulators for treating and preventing immune reconstitution inflammatory syndrome (iris)
|
|
WO2017117118A1
(en)
|
2015-12-28 |
2017-07-06 |
Celgene Corporation |
Compositions and methods for inducing conformational changes in cereblon and other e3 ubiquitin ligases
|
|
CN110248678A
(zh)
|
2016-12-03 |
2019-09-17 |
朱诺治疗学股份有限公司 |
调节car-t细胞的方法
|
|
CN118948892A
(zh)
|
2017-05-01 |
2024-11-15 |
朱诺治疗学股份有限公司 |
细胞疗法与免疫调节化合物的组合
|
|
AU2018275894B2
(en)
|
2017-06-02 |
2025-04-24 |
Juno Therapeutics, Inc. |
Articles of manufacture and methods for treatment using adoptive cell therapy
|
|
JP2020526194A
(ja)
|
2017-06-29 |
2020-08-31 |
ジュノー セラピューティクス インコーポレイテッド |
免疫療法薬と関連する毒性を評価するためのマウスモデル
|
|
WO2019067792A1
(en)
|
2017-09-28 |
2019-04-04 |
Celularity, Inc. |
TUMOR CONTROL WITH INTERMEDIATE NATURAL KILLER CELLS DERIVED FROM HUMAN PLACENTA (PINK) IN COMBINATION WITH ANTIBODY
|
|
SG11202003501XA
(en)
|
2017-11-01 |
2020-05-28 |
Juno Therapeutics Inc |
Antibodies and chimeric antigen receptors specific for b-cell maturation antigen
|
|
WO2019089858A2
(en)
|
2017-11-01 |
2019-05-09 |
Juno Therapeutics, Inc. |
Methods of assessing or monitoring a response to a cell therapy
|
|
MA51184A
(fr)
|
2017-12-15 |
2020-10-21 |
Juno Therapeutics Inc |
Molécules de liaison à l'anti-cct5 et procédés d'utilisation associés
|
|
CA3089414A1
(en)
*
|
2018-01-29 |
2019-08-01 |
Shijiazhuang Sagacity New Drug Development Company, Ltd. |
Crystal form of 1h-imidazo[4,5-b]pyridine-2(3h)-one compound and preparation process therefor
|
|
BR112020017053A2
(pt)
|
2018-02-21 |
2020-12-15 |
Celgene Corporation |
Anticorpos que se ligam ao bcma e usos dos mesmos
|
|
CA3117978A1
(en)
|
2018-11-08 |
2020-05-14 |
Juno Therapeutics, Inc. |
Methods and combinations for treatment and t cell modulation
|
|
IL283218B2
(en)
|
2018-11-16 |
2025-11-01 |
Juno Therapeutics Inc |
Dosing methods of engineered T cells for the treatment of malignant B cells
|
|
PT3886875T
(pt)
|
2018-11-30 |
2024-06-27 |
Juno Therapeutics Inc |
Métodos para tratamento utilizando terapia celular adotiva
|
|
SG11202107976SA
(en)
|
2019-01-29 |
2021-08-30 |
Juno Therapeutics Inc |
Antibodies and chimeric antigen receptors specific for receptor tyrosine kinase like orphan receptor 1 (ror1)
|
|
CN113527179B
(zh)
*
|
2020-04-13 |
2023-07-07 |
苏州璞正医药有限公司 |
链烃取代异吲哚啉-1,3-二酮类pde4抑制剂及其药物用途
|
|
CN113956190B
(zh)
*
|
2021-10-29 |
2023-05-02 |
大连理工大学 |
可激活肿瘤细胞焦亡的细胞器靶向光敏剂及其制备方法和应用
|
|
EP4543923A1
(en)
|
2022-06-22 |
2025-04-30 |
Juno Therapeutics, Inc. |
Treatment methods for second line therapy of cd19-targeted car t cells
|
|
WO2024097905A1
(en)
|
2022-11-02 |
2024-05-10 |
Celgene Corporation |
Methods of treatment with t cell therapy and immunomodulatory agent maintenance therapy
|